Temporary Disabled. :) please Go back droperidol - Wikidata www.fgks.org » Address: [go: up one dir, main page] Include Form Remove Scripts Accept Cookies Show Images Show Referer Rotate13 Base64 Strip Meta Strip Title Session Cookies droperidol (Q174259) From Wikidata Jump to navigation Jump to search chemical compoundMcN-JR-4749R-47491-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one1-{1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl}-2-benzimidazolinone1-{1-[4-(p-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl}-2-benzimidazolinone1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[d]imidazol-2-one edit Language Label Description Also known as English droperidol chemical compound McN-JR-4749R-47491-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one1-{1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl}-2-benzimidazolinone1-{1-[4-(p-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl}-2-benzimidazolinone1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[d]imidazol-2-one Statements instance of type of chemical entity 0 references subclass of heterocyclic compound 0 references has use medication 0 references chemical structure Droperidol.svg512 × 248; 5 KB 1 reference imported from Wikimedia project German Wikipedia mass 379.169605 dalton 1 reference stated in PubChem PubChem CID 3168 language of work or name English title droperidol (English) retrieved 3 October 2016 chemical formula C₂₂H₂₂FN₃O₂ 1 reference stated in PubChem PubChem CID 3168 language of work or name English title droperidol (English) retrieved 19 November 2016 canonical SMILES C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F 1 reference stated in PubChem PubChem CID 3168 language of work or name English title droperidol (English) retrieved 19 November 2016 defined daily dose 2.5 milligram route of administration parenteral route of administration 1 reference reference URL https://www.whocc.no/atc_ddd_index/?code=N05AD08 World Health Organisation international non-proprietary name droperidol (English) 1 reference stated in ChEBI ChEBI ID 4717 language of work or name English title droperidol (English) retrieved 3 October 2016 droperidolum (Latin) 0 references medical condition treated schizophreniform disorder 1 reference stated in NDF-RT NDF-RT ID N0000147316 language of work or name English retrieved 13 December 2016 pain 1 reference stated in NDF-RT NDF-RT ID N0000147316 language of work or name English retrieved 13 December 2016 significant drug interaction bepridil 1 reference stated in High-priority drug–drug interactions for use in electronic health records disopyramide 1 reference stated in High-priority drug–drug interactions for use in electronic health records amiodarone 1 reference stated in High-priority drug–drug interactions for use in electronic health records anagrelide 1 reference stated in High-priority drug–drug interactions for use in electronic health records arsenic trioxide 1 reference stated in High-priority drug–drug interactions for use in electronic health records astemizole 1 reference stated in High-priority drug–drug interactions for use in electronic health records azithromycin 1 reference stated in High-priority drug–drug interactions for use in electronic health records chloroquine 1 reference stated in High-priority drug–drug interactions for use in electronic health records chlorpromazine 1 reference stated in High-priority drug–drug interactions for use in electronic health records cisapride 1 reference stated in High-priority drug–drug interactions for use in electronic health records (RS)-citalopram 1 reference stated in High-priority drug–drug interactions for use in electronic health records clarithromycin 1 reference stated in High-priority drug–drug interactions for use in electronic health records cocaine 1 reference stated in High-priority drug–drug interactions for use in electronic health records dofetilide 1 reference stated in High-priority drug–drug interactions for use in electronic health records domperidone 1 reference stated in High-priority drug–drug interactions for use in electronic health records dronedarone 1 reference stated in High-priority drug–drug interactions for use in electronic health records erythromycin 1 reference stated in High-priority drug–drug interactions for use in electronic health records escitalopram 1 reference stated in High-priority drug–drug interactions for use in electronic health records flecainide 1 reference stated in High-priority drug–drug interactions for use in electronic health records halofantrine 1 reference stated in High-priority drug–drug interactions for use in electronic health records haloperidol 1 reference stated in High-priority drug–drug interactions for use in electronic health records ibutilide 1 reference stated in High-priority drug–drug interactions for use in electronic health records mesoridazine 1 reference stated in High-priority drug–drug interactions for use in electronic health records (RS)-methadone 1 reference stated in High-priority drug–drug interactions for use in electronic health records moxifloxacin 1 reference stated in High-priority drug–drug interactions for use in electronic health records ondansetron 1 reference stated in High-priority drug–drug interactions for use in electronic health records pentamidine 1 reference stated in High-priority drug–drug interactions for use in electronic health records pimozide 1 reference stated in High-priority drug–drug interactions for use in electronic health records probucol 1 reference stated in High-priority drug–drug interactions for use in electronic health records procainamide 1 reference stated in High-priority drug–drug interactions for use in electronic health records quinidine 1 reference stated in High-priority drug–drug interactions for use in electronic health records sevoflurane 1 reference stated in High-priority drug–drug interactions for use in electronic health records sotalol 1 reference stated in High-priority drug–drug interactions for use in electronic health records sparfloxacin 1 reference stated in High-priority drug–drug interactions for use in electronic health records (RS)-sulpiride 1 reference stated in High-priority drug–drug interactions for use in electronic health records terfenadine 1 reference stated in High-priority drug–drug interactions for use in electronic health records thioridazine 1 reference stated in High-priority drug–drug interactions for use in electronic health records amiodarone side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions ondansetron side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions arsenic trioxide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions disopyramide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions erythromycin side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clarithromycin side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorpromazine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-citalopram side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions paliperidone side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clomipramine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions apomorphine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions anagrelide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions moxifloxacin side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions dronedarone side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions crizotinib side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions pimozide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions zuclopenthixol side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions pasireotide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-hydroxyzine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-sulpiride side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-methadone side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions vandetanib side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions tetrabenazine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions risperidone side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions haloperidol side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions pentamidine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions mefloquine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions loxapine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions domperidone side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions toremifene side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions sotalol side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions lithium side effect long QT syndrome 1 reference sourcing circumstances probably stated in A reference set of clinically relevant adverse drug-drug interactions fingolimod side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bendroflumethiazide side effect Achor-Smith syndrom 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorthalidone side effect Achor-Smith syndrom 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (2RS,6RS)-clopamide side effect Achor-Smith syndrom 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bumetanide side effect Achor-Smith syndrom 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions furosemide side effect Achor-Smith syndrom 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions hydrochlorothiazide side effect Achor-Smith syndrom 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions indapamide side effect Achor-Smith syndrom 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions ivabradine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions paliperidone side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions trimipramine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amitriptyline side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bromocriptine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions risperidone side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (E/Z)-doxepin side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bendroflumethiazide side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions nicardipine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions diltiazem side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amlodipine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions felodipine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions sotalol side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorthalidone side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions cabergoline side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions lacidipine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions zuclopenthixol side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions periciazine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (2RS,6RS)-clopamide side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-sulpiride side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions pimozide side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions aripiprazole side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (−)-selegiline side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions haloperidol side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions quetiapine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions imipramine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions levodopa side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorpromazine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clomipramine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clozapine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions apomorphine side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bumetanide side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions furosemide side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions spironolactone side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions hydrochlorothiazide side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions indapamide side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amiodarone side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions trimipramine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions trimipramine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions trimipramine side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions trimipramine side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amitriptyline side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amitriptyline side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amitriptyline side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amitriptyline side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (E/Z)-doxepin side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (E/Z)-doxepin side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (E/Z)-doxepin side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (E/Z)-doxepin side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions ondansetron side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions ondansetron side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions ondansetron side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bendroflumethiazide side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bendroflumethiazide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bendroflumethiazide side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bendroflumethiazide side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions nicardipine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions nicardipine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions nicardipine side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions nicardipine side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions diltiazem side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions diltiazem side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions diltiazem side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions diltiazem side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amlodipine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amlodipine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amlodipine side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions amlodipine side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions arsenic trioxide side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions arsenic trioxide side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions arsenic trioxide side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions disopyramide side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions disopyramide side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions disopyramide side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions felodipine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions felodipine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions felodipine side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions felodipine side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorthalidone side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorthalidone side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorthalidone side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorthalidone side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions pentamidine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions pentamidine side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions pentamidine side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions erythromycin side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions erythromycin side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions erythromycin side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clarithromycin side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clarithromycin side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clarithromycin side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions lacidipine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions lacidipine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions lacidipine side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions lacidipine side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-mianserin side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-mianserin side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-mianserin side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-mianserin side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (2RS,6RS)-clopamide side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (2RS,6RS)-clopamide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (2RS,6RS)-clopamide side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (2RS,6RS)-clopamide side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions imipramine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions imipramine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions imipramine side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions imipramine side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorpromazine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorpromazine side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions chlorpromazine side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-citalopram side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-citalopram side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-citalopram side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clozapine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clozapine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clozapine side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions clozapine side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bumetanide side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bumetanide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bumetanide side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions bumetanide side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions furosemide side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions furosemide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions furosemide side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions furosemide side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions spironolactone side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions spironolactone side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions spironolactone side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions spironolactone side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions hydrochlorothiazide side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions hydrochlorothiazide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions hydrochlorothiazide side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions hydrochlorothiazide side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions indapamide side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions indapamide side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions indapamide side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions indapamide side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (±)-promethazine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions toremifene side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions sotalol side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions quetiapine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions ivabradine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions aripiprazole side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-sulpiride side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions pethidine side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions pethidine side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions periciazine side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions tramadol side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions tramadol side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions morphine side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions morphine side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions oxycodone side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions oxycodone side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions hydromorphone side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions hydromorphone side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions dihydrocodeine side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions dihydrocodeine side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions codeine side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions codeine side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions tapentadol side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions tapentadol side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-methadone side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions (RS)-methadone side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions vandetanib side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions buprenorphine side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions buprenorphine side effect long QT syndrome 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions fentanyl side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions alfentanil side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions alfentanil side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions alfentanil side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions sufentanil side effect depressed level of consciousness 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions sufentanil side effect hypotension 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions lithium side effect extrapyramidal symptoms 1 reference sourcing circumstances probably stated in A reference set of clinically relevant adverse drug-drug interactions lithium side effect encephalopathy 1 reference sourcing circumstances probably stated in A reference set of clinically relevant adverse drug-drug interactions lithium side effect dyskinesia 1 reference sourcing circumstances probably stated in A reference set of clinically relevant adverse drug-drug interactions lithium side effect asthenia 1 reference sourcing circumstances probably stated in A reference set of clinically relevant adverse drug-drug interactions lithium side effect brain injury 1 reference sourcing circumstances probably stated in A reference set of clinically relevant adverse drug-drug interactions fingolimod side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions tetrabenazine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions loxapine side effect cognitive disorder 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions loxapine side effect central respiratory depression 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions loxapine side effect sedation 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions loxapine side effect syncope 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions risperidone side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions risperidone side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions risperidone side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions mefloquine side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions mefloquine side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions mefloquine side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions haloperidol side effect cardiotoxicity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions haloperidol side effect torsades de pointes 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions haloperidol side effect pulseless electrical activity 1 reference sourcing circumstances hypothetically stated in A reference set of clinically relevant adverse drug-drug interactions physically interacts with Dopamine receptor D3 subject has role antagonist 1 reference stated in Open Targets Platform retrieved 14 August 2023 reference URL https://platform.opentargets.org/drug/CHEMBL1108 Dopamine receptor D4 subject has role antagonist 1 reference stated in Open Targets Platform retrieved 14 August 2023 reference URL https://platform.opentargets.org/drug/CHEMBL1108 5-hydroxytryptamine receptor 2A subject has role antagonist 1 reference stated in Open Targets Platform retrieved 14 August 2023 reference URL https://platform.opentargets.org/drug/CHEMBL1108 legal status (medicine) boxed warning 1 reference reference URL https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802 title FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English) manufacturer Pfizer 1 reference reference URL https://www.pfizer.com/products/product-list subject has role dopamine antagonist 1 reference stated in NDF-RT NDF-RT ID N0000147316 retrieved 5 March 2018 antipsychotics 1 reference stated in Medical Subject Headings MeSH descriptor ID D004329 retrieved 15 March 2018 Dopamine D2 Receptor Antagonists 1 reference stated in Medical Subject Headings MeSH descriptor ID D004329 retrieved 15 March 2018 antiemetic 1 reference stated in Medical Subject Headings MeSH descriptor ID D004329 retrieved 15 March 2018 anesthesia adjuvants 1 reference stated in Medical Subject Headings MeSH descriptor ID D004329 retrieved 15 March 2018 MCN code 2933.39.12 0 references has part(s) nitrogen 0 references oxygen 0 references fluorine 0 references carbon 0 references Commons category Droperidol 0 references Identifiers InChI InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28) 1 reference stated in PubChem PubChem CID 3168 language of work or name English title droperidol (English) retrieved 19 November 2016 InChIKey RMEDXOLNCUSCGS-UHFFFAOYSA-N 2 references stated in PubChem PubChem CID 3168 language of work or name English title droperidol (English) retrieved 19 November 2016 stated in ChEBI release 2020-09-01 CAS Registry Number 548-73-2 2 references stated in Global Substance Registration System UNII O9U0F09D5X language of work or name English title droperidol (English) retrieved 19 November 2016 InChIKey RMEDXOLNCUSCGS-UHFFFAOYSA-N stated in CAS Common Chemistry retrieved 9 April 2021 reference URL https://commonchemistry.cas.org/detail?cas_rn=548-73-2 ChemSpider ID 3056 1 reference stated in ChemSpider ChemSpider ID 3056 language of work or name English title Droperidol (English) retrieved 19 November 2016 PubChem CID 3168 2 references stated in PubChem PubChem CID 3168 language of work or name English title droperidol (English) retrieved 19 November 2016 matched by identifier from InChIKey InChIKey RMEDXOLNCUSCGS-UHFFFAOYSA-N Reaxys registry number 579168 1 reference stated in ChEBI ChEBI ID 4717 language of work or name English title droperidol (English) retrieved 3 October 2016 ChEBI ID 4717 mapping relation type exact match 2 references stated in ChEMBL ChEMBL ID CHEMBL1108 language of work or name English title DROPERIDOL (English) retrieved 19 November 2016 matched by identifier from International Chemical Identifier InChI InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28) ChEMBL ID CHEMBL1108 1 reference stated in ChEMBL ChEMBL ID CHEMBL1108 language of work or name English title DROPERIDOL (English) retrieved 19 November 2016 SureChEMBL ID SCHEMBL41426 2 references based on heuristic inferred from InChIKey matched by identifier from InChIKey InChIKey RMEDXOLNCUSCGS-UHFFFAOYSA-N UniChem compound ID 530651 1 reference stated in UniChem MassBank accession ID MSBNK-Athens_Univ-AU120701 0 references MSBNK-Athens_Univ-AU120702 0 references MSBNK-Athens_Univ-AU120703 0 references MSBNK-Athens_Univ-AU120704 0 references MSBNK-Athens_Univ-AU120705 0 references MSBNK-Athens_Univ-AU120707 0 references MSBNK-Athens_Univ-AU120708 0 references MSBNK-Athens_Univ-AU120709 0 references MSBNK-Athens_Univ-AU120710 0 references MSBNK-Athens_Univ-AU120711 0 references MSBNK-Athens_Univ-AU120730 0 references MSBNK-Athens_Univ-AU120731 0 references MSBNK-Athens_Univ-AU120732 0 references MSBNK-Eawag-EQ367901 0 references MSBNK-Eawag-EQ367902 0 references MSBNK-Eawag-EQ367903 0 references MSBNK-Eawag-EQ367904 0 references MSBNK-Eawag-EQ367905 0 references MSBNK-Eawag-EQ367906 0 references MSBNK-Eawag-EQ367907 0 references MSBNK-Eawag-EQ367908 0 references MSBNK-Eawag-EQ367909 0 references MSBNK-Waters-WA000411 0 references MSBNK-Waters-WA000412 0 references MSBNK-Waters-WA000413 0 references MSBNK-Waters-WA000414 0 references MSBNK-Waters-WA000415 0 references MSBNK-Waters-WA000416 0 references SPLASH splash10-0006-0900000000-418e20f120e395aac71a 0 references splash10-014i-0900000000-2888306b46b834e3dd3b 0 references splash10-014i-0900000000-0cff909ec834cc05a2d3 0 references splash10-00xr-0900000000-f910b21f009854002b17 0 references splash10-001l-0609000000-b071b906d4d1f94ae833 0 references splash10-00kf-0900000000-ac3d815681b1b57a53b5 0 references splash10-014i-0900000000-b2c3fb5ea6889dbf960c 0 references splash10-00xr-0900000000-01bdbb9758cd0acb8864 0 references splash10-00di-0900000000-09ecdeee9f023e5ac679 0 references splash10-00di-0900000000-be69940105e80f5ab869 0 references splash10-00di-2900000000-9a55a536e908d6236924 0 references splash10-00fr-9800000000-4462513b0f99ffd6ce93 0 references splash10-00b9-9200000000-b61d87593ee28d4b283e 0 references HSDB ID 3320 1 reference stated in Hazardous Substances Data Bank HSDB ID 3320 publication date 28 October 2019 title DROPERIDOL (English) retrieved 10 May 2021 DSSTox substance ID DTXSID6022973 2 references stated in Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard matched by identifier from InChIKey InChIKey RMEDXOLNCUSCGS-UHFFFAOYSA-N DSSTOX compound identifier DTXCID302973 0 references NSC number 169874 0 references 757819 0 references EC number 208-957-8 1 reference stated in Global Substance Registration System UNII O9U0F09D5X language of work or name English title droperidol (English) retrieved 19 November 2016 ECHA Substance Infocard ID 100.008.144 1 reference stated in ECHA Substance Infocard database ECHA Substance Infocard ID 100.008.144 retrieved 27 December 2018 title Droperidol (English) quotation CAS no.: 548-73-2 (English) AICS Chemical ID (BEING DELETED) 4836 0 references ATC code N05AD08 1 reference stated in DrugBank DrugBank ID 00450 language of work or name English title Droperidol (English) publication date 17 November 2015 Guide to Pharmacology Ligand ID 7172 1 reference stated in IUPHAR/BPS Guide to PHARMACOLOGY Guide to Pharmacology Ligand ID 7172 language of work or name English title droperidol (English) retrieved 19 November 2016 MeSH descriptor ID D004329 subject named as Droperidol 0 references MeSH concept ID M0006807 0 references MeSH tree code D02.522.352.343 0 references D03.633.100.103.393 0 references RxNorm ID 3648 1 reference stated in Global Substance Registration System UNII O9U0F09D5X language of work or name English title droperidol (English) retrieved 19 November 2016 DrugBank ID DB00450 1 reference matched by identifier from InChIKey InChIKey RMEDXOLNCUSCGS-UHFFFAOYSA-N Human Metabolome Database ID HMDB0014593 2 references based on heuristic inferred from InChIKey matched by identifier from InChIKey InChIKey RMEDXOLNCUSCGS-UHFFFAOYSA-N UNII O9U0F09D5X 2 references stated in Global Substance Registration System UNII O9U0F09D5X language of work or name English title droperidol (English) retrieved 19 November 2016 matched by identifier from InChIKey InChIKey RMEDXOLNCUSCGS-UHFFFAOYSA-N PatientsLikeMe treatment ID droperidol 0 references NDF-RT ID N0000147316 1 reference stated in Global Substance Registration System UNII O9U0F09D5X language of work or name English title droperidol (English) retrieved 19 November 2016 Probes And Drugs ID PD001512 0 references DrugCentral ID 966 1 reference stated in UniChem KEGG ID D00308 1 reference stated in ChEBI ChEBI ID 4717 language of work or name English title droperidol (English) retrieved 3 October 2016 CAB ID 138776 1 reference stated in CAB Thesaurus retrieved 6 April 2020 Freebase ID /m/09ht2f 1 reference stated in Freebase Data Dumps publication date 28 October 2013 KBpedia ID Droperidol 1 reference stated in KBpedia retrieved 9 July 2020 Microsoft Academic ID 2779425338 0 references OpenAlex ID C2779425338 1 reference stated in OpenAlex retrieved 26 January 2022 reference URL https://docs.openalex.org/download-snapshot/snapshot-data-format UMLS CUI C0013136 1 reference stated in Global Substance Registration System UNII O9U0F09D5X language of work or name English title droperidol (English) retrieved 19 November 2016 UNSPSC Code 51141728 0 references WikiProjectMed ID Droperidol 0 references Sitelinks Wikipedia(22 entries) edit arwiki دروبيريدول azbwiki دروپردیول cywiki Droperidol dewiki Droperidol enwiki Droperidol eswiki Droperidol fawiki دروپردیول fiwiki Droperidoli frwiki Dropéridol huwiki Droperidol idwiki Droperidol itwiki Droperidolo jawiki ドロペリドール orwiki ଡ୍ରୋପେରିଡୋଲ plwiki Droperydol ptwiki Droperidol rowiki Droperidol ruwiki Дроперидол shwiki Droperidol srwiki Droperidol svwiki Droperidol trwiki Droperidol Wikibooks(0 entries) edit Wikinews(0 entries) edit Wikiquote(0 entries) edit Wikisource(0 entries) edit Wikiversity(0 entries) edit Wikivoyage(0 entries) edit Wiktionary(0 entries) edit Multilingual sites(1 entry) edit commonswiki Category:Droperidol Navigation menu Personal tools EnglishNot logged inTalkContributionsCreate accountLog in Namespaces ItemDiscussion English Views ReadView history More Search Navigation Main pageCommunity portalProject chatCreate a new ItemRecent changesRandom ItemQuery ServiceNearbyHelpDonate Lexicographical data Create a new LexemeRecent changesRandom Lexeme Tools What links hereRelated changesSpecial pagesPermanent linkPage informationConcept URICite this pageGet shortened URLDownload QR code Print/export Create a bookDownload as PDFPrintable version